Aktis Oncology, Inc.

AKTS | Nasdaq | CIK: 0002035832 | SIC: 2834 Pharmaceutical Preparations | active
Aktis Oncology is a clinical-stage oncology company developing targeted radiopharmaceuticals using a proprietary miniprotein radioconjugate platform. Its lead candidate, [225Ac]Ac-AKY-1189, targets Nectin-4 and is in Phase 1b trials for locally advanced or metastatic urothelial cancer and other solid tumors. The company focuses on alpha-emitting radioisotopes, end-to-end supply chain development, and expanding radiopharmaceutical use beyond traditional nuclear medicine settings.
oncologyradiopharmaceuticalsurothelial-cancerbreast-cancerlung-cancertargeted-cancer-therapycgmp-(current-good-manufacturing-practice)dota-chelation-chemistryind-(investigational-new-drug)-regulatory-frameworksection-21-mrsa-(medicines-and-related-substances-act)
AI agents: Get this data as structured JSON (~200 tokens):
https://origin.rootz.global/api/company/AKTS
Profile | Timeline | SEC Filings | People

Products

NameTypeDescription
[225Ac]Ac-AKY-1189platformLead miniprotein radioconjugate targeting Nectin-4, conjugated to actinium-225 alpha-emitting radioisotope, in Phase 1b trials for urothelial cancer and other Nectin-4 expressing solid tumors.
AKY-1189 imaging radioconjugateplatformImaging radioisotope conjugated to AKY-1189 miniprotein for patient selection and tumor visualization prior to therapeutic treatment.
Miniprotein Radioconjugate PlatformplatformProprietary platform for discovering and developing precision radiopharmaceuticals using miniproteins of 40-70 amino acids to target solid tumors with alpha-emitting radioisotopes.

Partnerships

PartnerTypeDescription
Multiple domestic and international isotope suppliersstrategicPriority access agreements for actinium-225 supply to ensure supply chain continuity and redundancy.
Multiple contract manufacturersstrategicPartnerships for drug product production to create redundancies across supply chain components.

SEC Filings

View all SEC EDGAR filings: EDGAR Company Page

Structured filing index: /api/company/AKTS/filings

Origin — Data Provenance
This profile was extracted from SEC EDGAR filings (PEM-signed by sec.gov).
Every API response includes a cryptographic origin leaf for chain-of-custody tracking.
AI Discovery Document | Registry Metrics | GitHub